These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12763153)

  • 21. [Assessment of the implementation of the hemovigilance and transfusion safety system in French hospitals and blood transfusion centers].
    Fialon P; Quaranta JF; Lemonnier MP; Bricard H; Nublat M; Laxenaire MC; Blanloeil Y; Galperine I; Baron JF; Gross S; Fournel JJ; Vezon G; Janvier G
    Transfus Clin Biol; 1998 Jun; 5(3):193-202. PubMed ID: 9691363
    [No Abstract]   [Full Text] [Related]  

  • 22. An open call out on continual quality/safety improvement strategies in transfusion science and medicine.
    Seghatchian J
    Transfus Apher Sci; 2019 Oct; 58(5):697. PubMed ID: 31445932
    [No Abstract]   [Full Text] [Related]  

  • 23. [Blood transfusion safety in a limited resources setting: the elaboration of a rational National Blood Policy in Togo].
    Sodahlon YK; Segbena AY; Prince-David M; Gbo KA; Fargier MP; North ML; Malvy DJ
    Sante; 2004; 14(2):115-20. PubMed ID: 15454371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Error management: theory and application in transfusion medicine at a tertiary-care institution.
    Moore SB; Foss ML
    Arch Pathol Lab Med; 2003 Nov; 127(11):1517-22. PubMed ID: 14567748
    [No Abstract]   [Full Text] [Related]  

  • 25. Is haemovigilance improving transfusion practice?--The european experience.
    Strengers PF
    Dev Biol (Basel); 2007; 127():215-24. PubMed ID: 17486895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved safety of clinical blood transfusion in four provinces of China 1997-2005.
    Whyte G
    Dev Biol (Basel); 2007; 127():197-204. PubMed ID: 17486893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The case for standardization of transfusion medicine practices in French blood banks.
    Moncharmont P; Lacruche P; Planat B; Morizur A; Subtil E
    Transfus Med; 1999 Mar; 9(1):81-5. PubMed ID: 10216908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Continuous improvement of quality and implementation of a system for notification of noncompliance].
    Roussel P
    Transfus Clin Biol; 1999 Apr; 6(2):136-41. PubMed ID: 10339803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk management in transfusion medicine. The AIDS era underscores the need for a unified, comprehensive risk management program for all aspects of transfusion--from donor selection to post-transfusion outcomes.
    Berte LM; Dechristopher PJ
    MLO Med Lab Obs; 1996 Mar; 28(3):28-34. PubMed ID: 10156309
    [No Abstract]   [Full Text] [Related]  

  • 30. An overview of state efforts to improve transfusion medicine. The New York state model.
    Linden JV; Schmidt GB
    Arch Pathol Lab Med; 1999 Jun; 123(6):482-5. PubMed ID: 10383798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality assurance and standards for red cells and platelets.
    Sweeney J
    Vox Sang; 1998; 74 Suppl 2():201-5. PubMed ID: 9704446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Blood transfusion audit methodology: the auditors, reference systems and audit guidelines].
    Chevrolle F; Hadzlik E; Arnold J; Hergon E
    Transfus Clin Biol; 2000 Dec; 7(6):559-62. PubMed ID: 11204842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality Control Approach to Anticoagulants and Transfusion.
    McKean E
    Otolaryngol Clin North Am; 2016 Jun; 49(3):563-75. PubMed ID: 27267011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood safety in developing countries.
    Gibbs WN; Corcoran P
    Vox Sang; 1994; 67(4):377-81. PubMed ID: 7701809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Blood surveillance in Europe].
    Faber JC
    Transfus Clin Biol; 2000 Feb; 7(1):5-8. PubMed ID: 10730340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Standards, accreditation and proficiency testing in the management of blood and blood products in hospitals.
    Growe GH
    CMAJ; 1996 Mar; 154(6):755. PubMed ID: 8634948
    [No Abstract]   [Full Text] [Related]  

  • 37. Applying quality improvement tools in the transfusion service.
    Butch SH
    Clin Lab Sci; 2007; 20(2):113-21. PubMed ID: 17557710
    [No Abstract]   [Full Text] [Related]  

  • 38. Transposition of the Blood Directive into national law--the perspective of Portugal.
    Gonçalves MH; Muon MC; Gonçalves Jd
    Transfus Clin Biol; 2005 Feb; 12(1):18-20. PubMed ID: 15814287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haemovigilance: concept, Europe and UK initiatives.
    McClelland B; Love E; Scott S; Williamson LM
    Vox Sang; 1998; 74 Suppl 2():431-9. PubMed ID: 9704478
    [No Abstract]   [Full Text] [Related]  

  • 40. [Audit of labile blood product supplies].
    Cabaud JJ
    Transfus Clin Biol; 2000 Jun; 7 Suppl 1():75s-79s. PubMed ID: 10919230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.